Funding is being provided to support vaccine development. A significant investment has been made to accelerate efforts. This work is focused on addressing a specific outbreak.
Details about the vaccine and its potential use are available from global health organizations. These organizations have noted the vaccine's existing safety data. Further information can be found through the relevant health groups and their announcements.
Recent coverage curated from local and regional sources.
. Dans sa recommandation, l’OMS évoque l’importante quantité de données disponibles sur l’innocuité et l’immunogénicité d’Ervebo, qui a cont…
. In its recommendation, WHO noted the large amount of safety and immunogenicity data available for Ervebo – which has been used to help con…
.
. Key Messages • Self-organised displacement should not be equated with a lack of need for assistance. Many vulnerable people displace throu…
. This Flash Update is produced by OCHA Colombia in collaboration with humanitarian partners, based on official reports (as of 13 August, 18…
.
Countries: Lebanon, Israel . In August 2025, the Security Council unanimously decided to extend the mandate of the UN Interim Force in Leban…
. In this locality located approximately 65 kilometres south of Bunia, in Ituri Province, demobilized former combatants are actively partici…
. Entre la mi-juillet et la fin juillet 2026, plus de 80 000 personnes ont reçu une assistance dans les provinces de l’Ituri, du Nord-Kivu e…
. More than 80,000 people in the provinces of Ituri, North Kivu and South Kivu received assistance between mid-July and the end of July this…
. Background South Sudan continues to face a complex humanitarian crisis driven by conflict, climate-related shocks, disease outbreaks, disp…
. Summary This infographic report from April-June 2026 details logistics achievements in South Sudan, including cargo transport by various m…
Free weekly digest. Local news that actually matters — no spam, no clickbait, easy unsubscribe.
By subscribing you agree to our privacy policy. We never sell your data.